Avrum E. Spira – Candidate for Board of Directors of AACR
The voting for the 2025 AACR Annual Election is now open, where members will vote for the next President-Elect, Treasurer, five Board Members, and four members of the Nominating Committee. This year, Avrum E. Spira, MD, MSc is a candidate for the Board of Directors of AACR.
About the role
Dr. Spira is the founding chief of the Division of Computational Biomedicine in the Department of Medicine at Boston University, where he also serves as a professor of Medicine, Pathology, and Bioinformatics. He is the director of the J&J Innovation Lung Cancer Center and holds the Alexander Graham Bell Professorship in Healthcare Entrepreneurship. Additionally, he is an attending physician in the Medical Intensive Care Unit at Boston Medical Center and the global head of the Lung Cancer Initiative/Interventional Oncology at Johnson & Johnson.
Responsibilities
- Director of the J&J Innovation Lung Cancer Center
- Global Head of the Lung Cancer Initiative/Interventional Oncology at Johnson & Johnson
- Director of the Boston University-Boston Medical Center Cancer Center (2015-2018)
- Director of the Translational Bioinformatics Program at the Clinical Translational Science Institute (2008-2018)
- Attending Physician in the Medical Intensive Care Unit at Boston Medical Center
- Global Head of the Lung Cancer Initiative/Interventional Oncology at Johnson & Johnson
Requirements
Dr. Spira has held various academic roles in bioinformatics, pathology, and medicine at Boston University and Boston Medical Center, including associate professor and assistant professor positions. He has also directed the Bioinformatics and Systems Biology Program at the Pulmonary Center from 2005 to 2011.
Qualifications
Dr. Spira's research focuses on translational bioinformatics and molecular biology, with a particular emphasis on understanding airway genomic alterations linked to smoking-related lung diseases. His work aims to advance the early detection of lung cancer and explore strategies for lung cancer interception. He has made significant contributions to the American Association for Cancer Research (AACR) through various leadership roles and service activities.
Skills
- Translational Bioinformatics
- Molecular Biology
- Understanding Airway Genomic Alterations
- Early Detection of Lung Cancer
- Strategies for Lung Cancer Interception
Benefits
Dr. Spira has been involved in multiple AACR committees, including the AACR-Johnson & Johnson Lung Cancer Innovation Science Grants Joint Steering Committee and the AACR Team Science Award Committee. He has cochaired the Annual Meeting Program Committee (2016-2017) and been a member of the Cancer Prevention Committee and the Education and Training Committee.
Pay
N/A
Schedule
N/A
Benefits
N/A